LU B 22 (Fenofibrate 145 mg)

Pill imprint LU B 22 has been identified as Fenofibrate 145 mg.

Fenofibrate is used in the treatment of hypertriglyceridemia; hyperlipoproteinemia; hyperlipoproteinemia type iib, elevated ldl vldl; hyperlipoproteinemia type iia, elevated ldl; hyperlipoproteinemia type iv, elevated vldl (and more), and belongs to the drug class fibric acid derivatives. Risk cannot be ruled out during pregnancy. Fenofibrate 145 mg is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for LU B 22

Fenofibrate 145 mg LU B 22
Fenofibrate
Imprint:
LU
B 22
Strength:
145 mg
Color:
White
Shape:
Elliptical / Oval
Availability:
Prescription only
Drug Class:
Fibric acid derivatives
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Lupin Pharmaceuticals, Inc.
National Drug Code (NDC):
68180-0361
Inactive Ingredients:
crospovidone
hypromellose 2910 (3 mPa.s)
lactose monohydrate
magnesium stearate
polacrilin potassium
polyethylene glycol
polyvinyl alcohol
silicon dioxide
sodium lauryl sulfate
sucrose
magnesium silicate
titanium dioxide

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web2)